Vivo Capital, LLC Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$1.1T
Holdings
42
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (42 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SLNOSoleno Therapeutics Inc | 7,316,851 | $298.5B | 27.58% | |
| 2 | GONGeron Corp | 27,225,292 | $115.4B | 10.66% | |
| 3 | HRMYHarmony Biosciences Holdings Inc | 2,606,247 | $78.6B | 7.26% | |
| 4 | SVASinovac Biotech Ltd. | 11,800,000 | $76.3B | 7.05% | |
| 5 | DYNDyne Therapeutics Inc | 1,635,136 | $57.7B | 5.33% | |
| 6 | AVDLAvadel Pharmaceuticals PLC | 3,972,099 | $55.8B | 5.16% | |
| 7 | VRNAVerona Pharma PLC | 3,549,758 | $51.3B | 4.74% | |
| 8 | TERNTerns Pharmaceuticals Inc | 6,182,992 | $42.1B | 3.89% | |
| 9 | ALXOALX Oncology Holdings Inc | 4,220,048 | $25.4B | 2.35% | |
| 10 | VRDNViridian Therapeutics Inc | 1,678,207 | $21.8B | 2.02% | |
| 11 | CATBUSDAstria Therapeutics Inc | 2,329,027 | $21.2B | 1.96% | |
| 12 | SLNSilence Therapeutics PLC | 1,105,454 | $21.0B | 1.94% | |
| 13 | OLMAOlema Pharmaceuticals Inc | 1,873,704 | $20.3B | 1.87% | |
| 14 | COGTCogent Biosciences Inc | 2,244,941 | $18.9B | 1.75% | |
| 15 | ERASErasca Inc | 6,756,756 | $15.9B | 1.47% | |
| 16 | TARSTarsus Pharmaceuticals Inc | 565,550 | $15.4B | 1.42% | |
| 17 | DCTHDelcath Systems, Inc. | 1,666,746 | $14.0B | 1.29% | |
| 18 | RZLTRezolute Inc | 2,797,704 | $12.0B | 1.11% | |
| 19 | CELCCelcuity Inc | 610,500 | $10.0B | 0.92% | |
| 20 | SERASera Prognostics Inc | 1,650,440 | $9.8B | 0.90% | |
| 21 | CMPSCompass Pathway PLC | 1,608,000 | $9.7B | 0.90% | |
| 22 | ZLABZai Lab Ltd | 531,198 | $9.2B | 0.85% | |
| 23 | ORICOric Pharmaceuticals Inc | 1,269,676 | $9.0B | 0.83% | |
| 24 | RGLSRegulus Therapeutics Inc | 5,000,000 | $8.9B | 0.82% | |
| 25 | ABEOAbeona Therapeutics, Inc. | 1,842,751 | $7.8B | 0.72% | |
| 26 | TRMLTourmaline Bio Inc. | 591,882 | $7.6B | 0.70% | |
| 27 | CRBPCorbus Pharmaceuticals Holdings | 166,794 | $7.5B | 0.70% | |
| 28 | IOBTIO Biotech Inc | 6,173,439 | $7.2B | 0.67% | |
| 29 | TILInstil Bio Inc | 624,339 | $6.4B | 0.59% | |
| 30 | ENGNEngene Holdings Inc. | 678,705 | $6.4B | 0.59% | |
| 31 | VSTMVerastem Inc | 1,538,461 | $4.6B | 0.42% | |
| 32 | CMPXCompass Therapeutics Inc | 3,556,023 | $3.6B | 0.33% | |
| 33 | ALLKGUSDAllakos Inc | 2,988,000 | $3.0B | 0.28% | |
| 34 | BOLT1EURBolt Therapeutics Inc | 3,521,291 | $2.6B | 0.24% | |
| 35 | UNCYUnicycive Therapeutics | 3,470,152 | $1.7B | 0.16% | |
| 36 | ALGSAligos Therapeutics Inc | 3,547,030 | $1.2B | 0.11% | |
| 37 | CDXSCodexis, Inc | 388,144 | $1.2B | 0.11% | |
| 38 | DBVTDBV Technologies SA | 1,354,437 | $1.1B | 0.10% | |
| 39 | AVU0Adverum Biotechnologies, Inc. | 833,333 | $833.3M | 0.08% | |
| 40 | WHWKAadi Bioscience Inc | 509,572 | $744.0M | 0.07% | |
| 41 | QTTBQ32 Bio Inc. | 20,559 | $369.0M | 0.03% | |
| 42 | DTILPrecision Biosciences Inc | 4,675 | $45.5M | 0.00% |